Maharajgunj Medical Campus, Institute of Medicine, Tribhuwan University, Kathmandu, Nepal.
Maharajgunj Medical Campus, Institute of Medicine, Tribhuwan University, Kathmandu, Nepal.
Int J Cardiol. 2022 Jul 1;358:110-119. doi: 10.1016/j.ijcard.2022.04.010. Epub 2022 Apr 11.
Most countries in South Asia are endemic for rheumatic heart disease (RHD). We aimed to estimate the pooled prevalence of RHD in South Asia from population-based screening studies.
A systematic strategy was developed and used to search online databases for articles which described the prevalence of RHD in the South Asia region. Articles published in the English language between 1991 and 2021 were included in the review after fulfilling eligibility criteria.
The pooled prevalence of RHD in South Asia was 2.79 per 1000 (95% Confidence interval (CI): 1.30-4.83) according to studies using auscultation followed by echocardiography of suspected cases and 18.28 per 1000 (95% CI: 11.59-26.44) for studies using echocardiography screening of all participants. The highest prevalence of 8.0 per 1000 (95% CI: 0.71-22.74) was observed in Pakistan, whereas the lowest prevalence of 0.32 per 1000 (95% CI: 0.18-0.48) was observed in Bangladesh. The prevalence of RHD has decreased to 2.30 per 1000 from 3.06 per 1000 by 24.84% in 30 years (1991-2021). The prevalence is more than twice higher using WHF criteria compared to WHO criteria. We observed no sex-related differences in prevalence (p = 0.16).
The prevalence of RHD is still high in the South Asian population. Recent studies utilizing echocardiographic screening have identified subclinical cases of RHD, reflecting the significant burden of the disease in this region. More population-based echocardiography screening studies in every country in South Asia are required to estimate the accurate prevalence of the disease.
南亚大多数国家都存在风湿性心脏病(RHD)。我们旨在通过人群筛查研究估计南亚 RHD 的汇总患病率。
制定了一项系统策略,并用于在线数据库搜索描述南亚地区 RHD 患病率的文章。在符合入选标准后,纳入了 1991 年至 2021 年期间用英语发表的文章。
根据对疑似病例进行听诊并对其进行超声心动图检查的研究,南亚 RHD 的汇总患病率为每 1000 人 2.79(95%置信区间[CI]:1.30-4.83);根据对所有参与者进行超声心动图筛查的研究,南亚 RHD 的汇总患病率为每 1000 人 18.28(95%CI:11.59-26.44)。在巴基斯坦观察到的患病率最高,为 8.0 每 1000 人(95%CI:0.71-22.74),而在孟加拉国观察到的患病率最低,为每 1000 人 0.32(95%CI:0.18-0.48)。在 30 年(1991-2021 年)期间,患病率从每 1000 人 3.06 下降至每 1000 人 2.30,下降了 24.84%。与 WHO 标准相比,使用 WHF 标准时患病率高出两倍以上。我们没有观察到患病率存在性别差异(p=0.16)。
南亚人群中 RHD 的患病率仍然很高。最近利用超声心动图筛查的研究发现了亚临床 RHD 病例,反映了该地区疾病的严重负担。需要在南亚每个国家开展更多基于人群的超声心动图筛查研究,以估计疾病的准确患病率。